Trial NCT04952727
Publication Jin P, Lancet Reg. Health - West. Pac., 2023
Primary outcome on the report: GMT of neutralizing antibodies to wild-type SARS-CoV-2 at day 14 after vaccination.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.